Last edition
News about "familial chylomicronemia syndrome "
Arrowhead Pharmaceuticals Expands its New Patient-Centric Resources for FCS Patients
This new phase introduces a dedicated educational website, and the Spotlight on FCS white paper, which provides essential resources and support for those affected by Familial Chylomicronemia Syndrome (FCS).
Familial Chylomicronemia Syndrome | 03/03/2025 | By Aishwarya
Arrowhead Pharmaceuticals Secures FDA Breakthrough Therapy Designation for Plozasiran
Arrowhead intends to submit a New Drug Application to the FDA by year-end 2024 and plans to seek regulatory approval with additional global regulatory authorities thereafter.
Familial Chylomicronemia Syndrome | 13/09/2024 | By Aishwarya | 185
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy